- Filed
- Dec 11, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $126.12M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $125.65M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $254.34M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $271.92M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $67.72M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $65.91M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $203.07M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $201.23M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $287.46M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $303.16M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $359.88M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $374.27M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 18.46M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $6.96M |
| Capex | Q1 2025 · Mar 31, 2024 | $515K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$4.4M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $185.56M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $210.49M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.45 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$1.45 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $23.04M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $4.62M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$26.72M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$26.87M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $3.45M |
| Revenue | Q1 2025 · Mar 31, 2024 | $25.24M |